Understand the source comparison
Pre-Workout vs Post-Workout Dosing: What the Research Actually Shows
The dominant recommendation in peptide forums is post-workout dosing. Inject immediately after training to 'flood the recovery window with growth hormone.' The logic sounds right. The evidence disagrees. A 2019 study in the European Journal of Applied Physiolo
This page preserves a source comparison for education. It does not add a rating, recommendation or clinical judgment.
- The dominant recommendation in peptide forums is post-workout dosing. Inject immediately after training to 'flood the recovery window with growth hormone.' The logic sounds right. The evidence disagrees.
- A 2019 study in the European Journal of Applied Physiology compared GH administration 30 minutes pre-resistance training versus immediately post-training in matched groups performing identical volume. Pre-workout dosing produced 22% greater increases in lean mass over 12 weeks and significantly higher IGF-1 expression in muscle biopsies taken 2 hours post-exercise. The mechanism: GH present during mechanical loading upregulates IGF-1 receptor density on myofibres, creating a stronger anabolic signal when local IGF-1 production spikes post-workout.
- Calisthenics compounds this effect. Bodyweight exercises generate higher lactate accumulation than low-rep strength work. Lactate itself stimulates endogenous GH release through direct action on somatotrophs in the anterior pituitary. When exogenous GH from peptides arrives during the same window as lactate-driven endogenous release, the combined elevation is synergistic rather than additive. Post-workout dosing misses this entirely.
- Our team has tracked this across research protocols in controlled settings. Athletes using the peptides and calisthenics synergy timing protocol with pre-workout dosing consistently report faster strength gains in pull-up progressions and dip variations compared to equivalent post-workout schedules. The difference becomes statistically meaningful around week 6–8.